OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson
Biologics by McKesson joined a limited distribution network for OGSIVEO, the first FDA-approved drug for adults with progressing desmoid tumors requiring systemic treatment.